Global Bone Densitometer Devices Market - 2024-2031

Market Size

The Global Bone Densitometer Market reached US$ 311.36 million in 2023 and is expected to reach US$ 452.73 million by 2031, growing at a CAGR of 4.8% during the forecast period 2024-2031.

A bone densitometer is a medical imaging device employed to measure bone density to determine if the patient has osteoporosis, a disorder indicated by more fragile bones that are more likely to break. The densitometer utilizes X-rays to estimate how many grams of calcium and other bone minerals are filled into a segment of bone.

Bone Densitometer Market Trends

Growing Prevalence of Osteoporosis

The global market growth for Bone Densitometer Devices is expected to be driven by the growing prevalence of osteoporosis during the forecast period. According to the International Osteoporosis Foundation, there is an anticipated over 300% gain in hip fractures among males and a 240% boost among females by 2050. This highlights the necessity for bone examination, pushed by the increased preponderance of osteoporosis and corresponding disorders like osteopenia, osteomalacia, and osteoporotic fractures.

Globally, over 8.9 million fractures annually are rendered by osteoporosis, resulting in an osteoporotic rupture every 3 seconds, according to the IOF (International Osteoporosis Foundation). Moreover, the NIH estimated that over 200 million individuals suffer from osteoporosis. Moreover, statistics from the International Osteoporosis Foundation indicate that 1 in 3 females over the age of 50 years and 1 in 5 males are expected to encounter osteoporotic fractures in their lifetime.

Additionally, the growing geriatric population and increased research activities are among the additional factors boosting the global market during the forecast period.

High Cost of Bone Densitometer

However, the high cost of the bone densitometer is expected to hamper the global bone densitometer market growth during the forecast period. For instance, the early GE Prodigy Series, GE DPX series, and Hologic Discovery series cost roughly $16,000 to $21,000. The later GE Prodigy series, later Hologic Discovery series, and the early Hologic Horizon series cost $22,000 - $28,000 while the latest GE Prodigy series, GE iDXA, and Hologic Horizons A and W cost between $30,000 - $45,000 thus, slowing the global bone densitometer market growth during the forecast period.

Bone Densitometer Market Segmentation

The global bone densitometer devices market is segmented based on technology, application, end user and region.

Dual-Energy X-ray Absorptiometry (DEXA) Technology Segment is Expected to Dominate Market

During the forecast period, the global bone densitometer market is expected to be dominated by dual-energy X-ray absorptiometry (DEXA). DEXA is preferred over other bone densitometer device techniques because of its many advantages. By passing X-rays with two different energy levels from the bone, DEXA measures the proportion of calcium and minerals in the bones. Its advantages include low radiation dose, accuracy, and simplicity.

In addition, compared with computed tomography and magnetic resonance imaging, DXA provides very accurate readings of fat mass (FM) and lean mass (LM) values. According to Bone Journal, DEXA is the gold standard for estimating bone mineral density (BMD), diagnosing osteoporosis, and monitoring changes in BMD over time to determine fracture risk. Ultrasound is less frequently used than DEXA because there are no precise guidelines for using ultrasound measurement to diagnose osteoporosis or predict fracture risk. Therefore, based on the above data, it is expected that DEXA will continue to dominate the global bone densitometer device market throughout the forecast period.

Bone Densitometer Market Geographical Share

North America is Expected to Dominate the Global Market

North America is expected to hold the largest share of the global bone densitometer market throughout the forecast period. This is owing to the growing post-menopausal female population in the region. For instance, according to the North American Menopause Society, over 2 million US females attain menopause annually, and it is estimated that by 2026, nearly one-quarter of the Canadian residents will be females over 50. Moreover, the presence of major market players such as OSI Systems, Inc., Tecnicare Healthcare Co., Hologic, Inc., and GE Healthcare, who hold a substantial share of the bone densitometer market, ensures the dominance of this region.

These key players have captured a major share of the market via diverse market strategies such as product launches, partnerships, market approvals, acquisitions, collaborations, etc. Additionally, the new policy guidelines of different healthcare and insurance companies in the United States for the reimbursement of bone density studies are contributing to the dominance of this region over the global bone densitometer market. For example, UnitedHealthcare, in September 2022, approved Medicare coverage for Bone Mass Measurement (BMM), which is a radiologic, radioisotope, or other procedure.

COVID-19 Impact Analysis

The COVID-19 pandemic has significantly influenced the bone densitometer market since, according to the European Review for Medical and Pharmacological Sciences, there is the possibility of Secondary osteoporosis as a post-acute consequence of COVID-19. Thus, the bone health situation of patients outliving COVID-19 hospitalization needs to be observed closely at follow-up visits, facilitating the prevention and early treatment of osteoporosis complications.

Furthermore, according to Indiana University researchers, even a mild infection of COVID-19 can cause rapid and significant bone density loss, according to long-term research. Therefore, increasing the need for monitoring the bone density of the patients who suffered COVID-19 infection, increasing the demand for bone densitometer devices and positively impacting the global bone densitometer device market growth.

Key Developments

In May 2021, At the Florida Orthopedic Society Annual Scientific Meeting, Echolight introduced Radiofrequency Echographic Multi Spectrometry (REMS), the first radiation-free technology provided in the shape of a portable bone densitometer that can safely scan essential bone health indicators at a more elevated frequency than different testing methods.

In May 2021, Beckman Coulter, a clinical diagnostics leader, launched the DxA 5000 Fit, a workflow-automation solution developed to fit into medium-sized labs that execute less than 5,000 tests per day.

Bone Densitometer Market Key Players

The major global players in the market include GE Healthcare, BeamMed, Diagnostic Medical System, Eco light Healthcare, Hologic Inc., Medonica, Osteosys, Swissray, OSI Systems, Inc. and Tecnicare Healthcare Co.

Why Purchase the Report?

To visualize the global bone densitometer devices market segmentation based on technology, application, end user and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of bone densitometer devices market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key product of all the major players.

The global bone densitometer devices market report would provide approximately 61 tables, 58 figures and 182 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies